CrossrefInfokarte
Letter: Regenerative Medicine as a New Research Culture: From Translation to Responsible Clinical Access
Tissue Engineering Part C: Methods · 2026-10-01 · 32 (10-12) · 347-349
DOI: 10.1177/19373384261494728 ↗Abstract
Kein Abstract verfügbar.
EUVIMED